Literature DB >> 24399064

Noninvasive arterial blood pressure waveforms in patients with continuous-flow left ventricular assist devices.

Jerson R Martina1, Berend E Westerhof, Nicolaas de Jonge, Jeroen van Goudoever, Paul Westers, Steven Chamuleau, Diederik van Dijk, Ben F M Rodermans, Bas A J M de Mol, Jaap R Lahpor.   

Abstract

Arterial blood pressure and echocardiography may provide useful physiological information regarding cardiac support in patients with continuous-flow left ventricular assist devices (cf-LVADs). We investigated the accuracy and characteristics of noninvasive blood pressure during cf-LVAD support. Noninvasive arterial pressure waveforms were recorded with Nexfin (BMEYE, Amsterdam, The Netherlands). First, these measurements were validated simultaneously with invasive arterial pressures in 29 intensive care unit patients. Next, the association between blood pressure responses and measures derived by echocardiography, including left ventricular end-diastolic dimensions (LVEDDs), left ventricular end-systolic dimensions (LVESDs), and left ventricular shortening fraction (LVSF) were determined during pump speed change procedures in 30 outpatients. Noninvasive arterial blood pressure waveforms by the Nexfin monitor slightly underestimated invasive measures during cf-LVAD support. Differences between noninvasive and invasive measures (mean ± SD) of systolic, diastolic, mean, and pulse pressures were -7.6 ± 5.8, -7.0 ± 5.2, -6.9 ± 5.1, and -0.6 ± 4.5 mm Hg, respectively (all <10%). These blood pressure responses did not correlate with LVEDD, LVESD, or LVSF, while LVSF correlated weakly with both pulse pressure (r = 0.24; p = 0.005) and (dP(art)/dt)max (r = 0.25; p = 0.004). The dicrotic notch in the pressure waveform was a better predictor of aortic valve opening (area under the curve [AUC] = 0.87) than pulse pressure (AUC = 0.64) and (dP(art)/dt)max (AUC = 0.61). Patients with partial support rather than full support at 9,000 rpm had a significant change in systolic pressure, pulse pressure, and (dP(art)/dt)max during ramp studies, while echocardiographic measures did not change. Blood pressure measurements by Nexfin were reliable and may thereby act as a compliment to the assessment of the cf-LVAD patient.

Entities:  

Mesh:

Year:  2014        PMID: 24399064     DOI: 10.1097/MAT.0000000000000033

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

Review 1.  [Intensive care treatment of patients with left ventricular assist devices].

Authors:  B Steinlechner; Daniel Zimpfer; Arno Schiferer; Nikolaus Heinrich; Thomas Schlöglhofer; Angela Rajek; Martin Dworschak; Michael Hiesmayr
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-08-28       Impact factor: 0.840

2.  Continuous noninvasive monitoring of arterial pressure using the vascular unloading technique in comparison to the invasive gold standard in elderly comorbid patients: A prospective observational study.

Authors:  Phil Klose; Ulf Lorenzen; Rouven Berndt; Christoph Borzikowsky; Moritz Hill; Matthias Gruenewald; Gunnar Elke; Jochen Renner
Journal:  Health Sci Rep       Date:  2020-11-10

3.  Impact and Measurement of Blood Pressure During Continuous Flow Left Ventricular Assist Device Support: The Pressure Is On!

Authors:  Omar Saeed; Ulrich P Jorde
Journal:  ASAIO J       Date:  2019-02       Impact factor: 2.872

Review 4.  Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New "Gold Standard"?

Authors:  Massimo Capoccia
Journal:  J Cardiovasc Dev Dis       Date:  2016-12-12

5.  Suitable methods of measuring acceleration time in the diagnosis of internal carotid artery stenosis.

Authors:  Kentaro Iizuka; Hidehiro Takekawa; Akio Iwasaki; Haruki Igarashi; Keisuke Suzuki; Saro Kobayashi; Daisuke Tsukui; Koichi Hirata
Journal:  J Med Ultrason (2001)       Date:  2020-01-07       Impact factor: 1.314

6.  Accuracy of noninvasive continuous arterial pressure monitoring using ClearSight during one-lung ventilation.

Authors:  Sang-Wook Lee; Sangho Lee; Hyungtae Kim; Yun-Jong Kim; Mihyeon Kim; Jeong-Hyun Choi
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.